Analecto Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Analecto General Information
Description
Provider of CADseq technology designed to precisely detect and analyze latent HIV-infected cells for research, diagnostics, and precision medicine. The company offers DNA cleavage and fidelity sequencing to provide sensitive detection of chronic viral reservoirs, enabling clients to monitor drug efficacy and develop personalized treatment plans for HIV.
Contact Information
Website
www.analecto.comCorporate Office
- Sankt Paulsgatan 28B
- 118 48 Stockholm
- Sweden
Corporate Office
- Sankt Paulsgatan 28B
- 118 48 Stockholm
- Sweden
Analecto Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Nov-2024 | Completed | Generating Revenue |
Analecto Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DRIVE (KI Innovations Business Incubator) | Accelerator/Incubator |
Analecto FAQs
-
When was Analecto founded?
Analecto was founded in 2024.
-
Where is Analecto headquartered?
Analecto is headquartered in Stockholm, Sweden.
-
What industry is Analecto in?
Analecto’s primary industry is Decision/Risk Analysis.
-
Is Analecto a private or public company?
Analecto is a Private company.
-
What is Analecto’s current revenue?
The current revenue for Analecto is .
-
Who are Analecto’s investors?
DRIVE (KI Innovations Business Incubator) has invested in Analecto.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process